Ollie Super has moved in and out of cancer treatment since she was diagnosed with neuroblastoma as a toddler in foster care. Now 8, the second grader is dealing with it again. Her cancer came back late last year. Ollie’s parents, who adopted her in 2020, tried to sign her up for a clinical trial … Read more
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children’s cancer has spread at diagnosis in a way that can be compared between countries. While poorer survival following late-stage diagnosis is well recognised, the study is the first … Read more
In 2017, Stephanie Uy learned that her 22-month-old daughter, Aspen, had stage IV high-risk neuroblastoma. The cancer, which develops from the sympathetic nervous system, is the most common type of solid tumor in children outside of the brain. Patients with high-risk neuroblastoma tend to be older than 18 months at diagnosis, have amplification of the … Read more
New research shows that GD2 CAR-T cell therapy offers a potential cure for neuroblastoma, with some patients achieving long-term remission for over a decade—marking a major milestone in solid tumor treatment. Study: Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Image Credit: ART-ur / Shutterstock.com In a recent study published in Nature Medicine, … Read more